Context Therapeutics Inc. - Common Stock (CNTX)
CUSIP: 21077P108
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 91,741,639
- Total 13F shares
- 2,747,803
- Share change
- -156,617
- Total reported value
- $5,761,000
- Price per share
- $2.12
- Number of holders
- 17
- Value change
- -$388,653
- Number of buys
- 12
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 21077P108?
CUSIP 21077P108 identifies CNTX - Context Therapeutics Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 21077P108:
Top shareholders of CNTX - Context Therapeutics Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
1,165,100
|
$2,528,000 | — | 31 Mar 2022 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.85%
|
777,610
|
$1,687,000 | — | 31 Mar 2022 | |
| Worth Venture Partners, LLC |
13F
|
Company |
0.35%
|
317,729
|
$689,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.26%
|
236,279
|
$513,000 | — | 31 Mar 2022 | |
| Knoll Capital Management, LLC |
13F
|
Company |
0.15%
|
139,520
|
$303,000 | — | 31 Mar 2022 | |
| Veritable, L.P. |
13F
|
Company |
0.12%
|
110,249
|
$239,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
49,912
|
$108,000 | — | 31 Mar 2022 | |
| swisspartners Ltd. |
13F
|
Company |
0.05%
|
42,235
|
$92,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
20,309
|
$44,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
18,516
|
$40,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.02%
|
16,961
|
$37,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
10,000
|
$22,000 | — | 31 Mar 2022 | |
| Evan G. Dick |
3/4/5
|
Former Section 16 officer |
—
class O/S missing
|
29,223
|
— | — | 15 Feb 2022 | |
| William F. Rencher |
3/4/5
|
Former Section 16 officer |
—
class O/S missing
|
8,000
|
— | — | 15 Feb 2022 |
Institutional Holders of Context Therapeutics Inc. - Common Stock (CNTX) as of Q2 2022
As of 30 Jun 2022,
Context Therapeutics Inc. - Common Stock (CNTX) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,747,803 shares.
The largest 10 holders included
Affinity Asset Advisors, LLC, VANGUARD GROUP INC, Worth Venture Partners, LLC, AIGH Capital Management LLC, Knoll Capital Management, LLC, HighTower Advisors, LLC, Veritable, L.P., GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, and swisspartners Ltd..
This page lists
17
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
12
Q2 2022 holders
17
Holder diff
5
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.